In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Covidien Set to Compete in Vascular Business

Executive Summary

Covidien, following the acquisition of Vnus Medical Technologies and Bacchus Vascular, is establishing a global business unit focused on vascular surgery.

Related Content

Vein Device Companies Dig Deeper
Device M&A Poised For A Strong Year
Covidien - Back on Top: An Interview with Richard Meelia
Covidien Runs Familiar But Different Plays to Build Vascular Franchise
Embolic Protection: Unmet Clinical Need or Unneeded Technology
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q2 2009
NiTi Challenges Surgical Staple Market
Scoping out Gastroenterology Start-Ups
Market & Industry Briefs
Spun Out, Covidien Rolls On


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts